Prosecution Insights
Last updated: April 19, 2026
Application No. 17/819,147

DEVICE AND METHOD FOR COMMINUTION OF CIRCULATING TUMOR CELL CLUSTERS

Non-Final OA §103
Filed
Aug 11, 2022
Examiner
STRACHAN, KATE ELIZABETH
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Johannes Kepler Universität Linz
OA Round
3 (Non-Final)
41%
Grant Probability
Moderate
3-4
OA Rounds
4y 0m
To Grant
71%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allow Rate
33 granted / 81 resolved
-29.3% vs TC avg
Strong +31% interview lift
Without
With
+30.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
68 currently pending
Career history
149
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
69.8%
+29.8% vs TC avg
§102
16.9%
-23.1% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 81 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-13 are pending and currently under consideration for patentability. Claims 1, 4, 8, and 9 are newly amended. Response to Arguments Applicant’s arguments, see pages 4-15, filed 10/14/2025, with respect to claims 1-13 have been fully considered and are persuasive. The rejection of claims 1-13 has been withdrawn. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1, 2, 6, 10, and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Sohn (WO 9529716 A1). Regarding Claim 1, Sohn teaches a device for comminution or inactivation of circulating tumor cells (CTC) or tumor cell clusters (CTCC) from a tumor-affected organ or organ part, comprising: a pump (110) arranged inside an outer jacket tube (111) having a form factor configured for intracorporeal placement in a venous drain of the tumor-affected organ or organ part and venous blood flow between an inlet and a pump outlet(page 10, lines 14-30), which has a pressure-increasing section and a pressure- reducing throttle (116) arranged at the pump outlet, and corresponds on the output side in its design point given by volumetric flow (Q) and pumping pressure (p) to the volumetric flow and the blood pressure of the venous drain of the tumor-affected organ or organ part (claims 8-9), the combination of the pressure-increasing section (118) and the pressure-reducing throttle (116) at the pump outlet configured for providing shear stress on the venous blood flow effective for comminution or inactivation of CTCs and CTCCs, wherein the pump (110) comprises a micro-axial pump with a sequence of pressure-increasing blades arranged along a screw shaft of the micro-axial pump rotatable in the outer jacket tube (111) by a drive(page 10, lines 14-30), and the pressure-reducing throttle comprises a flow resistance structure projecting radially from the screw shaft of the micro-axial pump (figure 17) (page 10, lines 14-30), which flow resistance structure has a cylindrical section which forms a circular-cylindrical annular gap with the outer jacket tube enclosing the pressure-reducing throttle, to allow selective control of both shear stress and pressure differential on the blood removed at the inlet and ejected at the pump outlet (page 10, lines 14-30) (claim 17, 22). Sohn fails to explicitly teach inactivation of circulating tumor cells (CTC) or tumor cell clusters (CTCC) from a tumor-affected organ or organ part. It has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2d 1647 (1987). In this case, the device of Sohn could easily be used for circulating tumor cells (CTC) or tumor cell clusters (CTCC) from a tumor-affected organ or organ part. Regarding Claim 2, Sohn teaches the device according to claim 1. Sohn fails to teach wherein the volumetric flow of the pump in the design point is 0.1-1.5 liters/minute. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have the volumetric flow of the pump in the design point is 0.1-1.5 liters/minute in order to fit the particular procedure being done since this claimed dimension of the flow pump speed is non critical. Since applicant has not given any criticality to why the dimension disclosed has any importance to the function of the claimed device (see page 8, lines 23 of applicants specification), the Federal Circuit held that, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device. In Gardner v. TEC Syst., Inc., 725 F.2d 1338, 220 USPQ 777. Regarding Claim 6, Sohn teaches the device according to claim 1. Sohn further teaches wherein a coaxial, inner jacket tube which is fixed to the blades of the micro-axial pump is provided within the outer jacket tube (page 10, lines 14-30)(figure 17). Regarding Claim 10, Sohn teaches the device according to claim 2. Sohn further teaches wherein a coaxial, inner jacket tube which is fixed to the blades of the micro-axial pump is provided within the outer jacket tube (page 10, lines 14-30)(figure 17). Regarding Claim 12, Sohn teaches the device according to claim 4. Sohn further teaches wherein a coaxial, inner jacket tube which is fixed to the blades of the micro-axial pump is provided within the outer jacket tube (page 10, lines 14-30)(figure 17). Claim(s) 3-5, 7-9, 11, and 13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sohn (WO 9529716 A1) in view of Nitzan (US 20160331378 A1). Regarding Claim 3, Sohn teaches the device according to claim 1. However Sohn fails to teach wherein the pumping pressure of the pump is 4-20 hPa in the design point. In the same field of endeavor, Nitzan teaches wherein the pumping pressure of the pump is 4-20 hPa in the design point (paragraph [0104]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify Sohn wherein the pumping pressure of the pump is 4-20 hPa in the design point, similar to Nitzan, so the flow rate being adjustable can help the pump accommodate changes in the patient's condition over time and/or allow the pump to be driven at a selected rate for a particular patient (motivated by Nitzan, paragraph [0104]). Regarding Claim 4, Sohn teaches the device according to claim 1. However Sohn fails to teach wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft. Nitzan further teaches wherein before the pump and after the pressure-reducing throttle a respective pressure sensor (paragraph [0105]) is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft (paragraph [0024], [0107]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the pressure reducing throttle of Sohn, wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft, similar to Nitzan, can detect if the system is working as intended or if there is a medical issue. Regarding Claim 5, Sohn in view of Nitzan teaches the device according to claim 4. However Sohn fails to teach wherein the setpoint value predetermined for the pressure difference is 0. Nitzan further teaches wherein the setpoint value predetermined for the pressure difference is 0 (paragraph [0112]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify wherein the setpoint value predetermined for the pressure difference is 0, similar to Nitzan, so the flow is not disturbed by a change in pressure (motivated by Nitzan, paragraph [0112]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the pressure reducing throttle of Sohn, wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft, similar to Nitzan, can detect if the system is working as intended or if there is a medical issue. Regarding Claim 7, Sohn teaches the device according to claim 2. However Sohn fails to teach wherein the pumping pressure of the pump is 4-20 hPa in the design point. In the same field of endeavor, Nitzan teaches wherein the pumping pressure of the pump is 4-20 hPa in the design point (paragraph [0104]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify Sohn wherein the pumping pressure of the pump is 4-20 hPa in the design point, similar to Nitzan, so the flow rate being adjustable can help the pump accommodate changes in the patient's condition over time and/or allow the pump to be driven at a selected rate for a particular patient (motivated by Nitzan, paragraph [0104]). Regarding Claim 8, Sohn teaches the device according to claim 2. However Sohn fails to teach wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft. Nitzan further teaches wherein before the pump and after the pressure-reducing throttle a respective pressure sensor (paragraph [0112]) is provided, and a control unit (9), which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft (102) (paragraph [0104- 0105]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the pressure reducing throttle of Sohn, wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft, similar to Nitzan, can detect if the system is working as intended or if there is a medical issue. Regarding Claim 9, Sohn in view of Nitzan teaches the device according to claim 3. However Sohn fails to teach wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft. Nitzan further teaches wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit (9), which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft (102) (paragraph [0104- 0105]). Therefore, it would have been obvious to a person having ordinary skill in the art prior to the effective filing date of the claimed invention to modify the pressure reducing throttle of Sohn, wherein before the pump and after the pressure-reducing throttle a respective pressure sensor is provided, and a control unit, which controls the pressure difference of the pressure values measured by the two pressure sensors to a predetermined setpoint value by varying the speed of the screw shaft, similar to Nitzan, can detect if the system is working as intended or if there is a medical issue. Regarding Claim 11, Sohn in view of Nitzan teaches the device according to claim 3. Sohn further teaches wherein a coaxial, inner jacket tube which is fixed to the blades of the micro-axial pump is provided within the outer jacket tube (page 10, lines 14-30)(figure 17). Regarding Claim 13, Sohn in view of Nitzan teaches the device according to claim 5. Sohn further teaches wherein a coaxial, inner jacket tube which is fixed to the blades of the micro-axial pump is provided within the outer jacket tube (page 10, lines 14-30)(figure 17). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATE ELIZABETH STRACHAN whose telephone number is (571)272-7291. The examiner can normally be reached M-F: 8:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca Eisenberg can be reached on (571)-270-5879. The fax phone number for the organization where this application or proceeding is assigned is (571)-270-5879. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATE ELIZABETH STRACHAN/ Examiner, Art Unit 3781 /REBECCA E EISENBERG/Supervisory Patent Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Aug 11, 2022
Application Filed
Nov 15, 2024
Non-Final Rejection — §103
Feb 21, 2025
Response Filed
Jul 11, 2025
Final Rejection — §103
Oct 14, 2025
Response after Non-Final Action
Dec 09, 2025
Request for Continued Examination
Dec 21, 2025
Response after Non-Final Action
Jan 08, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599712
ELECTRO-MECHANICAL PUMP CONTROLLER FOR NEGATIVE-PRESSURE TREATMENT
2y 5m to grant Granted Apr 14, 2026
Patent 12539393
CATHETER
2y 5m to grant Granted Feb 03, 2026
Patent 12527949
SYSTEMS AND METHODS FOR PUMPING SALINE THROUGH A STERILIZING FILTER
2y 5m to grant Granted Jan 20, 2026
Patent 12521343
Two Stage Microchip Drug Delivery Device and Methods
2y 5m to grant Granted Jan 13, 2026
Patent 12478708
WOUND CARE DEVICE HAVING FLUID TRANSFER AND ADHESIVE PROPERTIES
2y 5m to grant Granted Nov 25, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
41%
Grant Probability
71%
With Interview (+30.6%)
4y 0m
Median Time to Grant
High
PTA Risk
Based on 81 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month